BeStock  
Stocks › Biotechnology › IONS

Ionis Pharmaceuticals IONS

US equityMarket cap rank #2142Biotechnology
$26.58 −$0.64 (-2.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.76 +0.68%
Open$26.93
Prev close$27.22
Day range$26.53 – $28.07
Volume3.19M
Market cap$4.43B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.7%+4.22 pts vs. prior quarter
Institutions holding595-34 vs. prior quarter
Insider trades (recent)29 buys / 21 sellsNet buying
ARK fund activity+100,241 sh1 recent transactions · last 20 Sep 2026
Short interest12.74% of floatDays to cover 8.4 · as of 30 Oct 2026
Short-sale volume share17.4%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%21%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$34.51M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$36.4MSuper+$1.9MBig−$8.0MMid−$6.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 45.3% of shares outstanding.

Largest holders

  • FMR14.85%
  • Capital Research13.28%
  • BlackRock7.92%
  • Vanguard Portfolio Management, LLC4.64%
  • Wellington Management Group4.59%
  • Vanguard Capital Management, LLC4.33%
  • T. Rowe Price Group, Inc.4.29%
  • Two Sigma Investments, LP3.75%

By investor type

  • Mutual Fund90.80%
  • Hedge Fund12.49%
  • Public Company6.14%
  • VC/PE Fund1.79%
  • Private Company1.69%
  • Government Pension Fund1.30%
  • Individual/Insider0.78%
  • Insurance Company0.29%

Reported short interest has risen from 12.58% to 12.74% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +2,488,174 7.9%
Morgan Stanley Public Company 2026/Q3 +1,862,501 1.9%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,862,501 1.9%
State Street Global Advisors Mutual Fund 2026/Q3 +1,376,052 3.4%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +1,013,883 0.7%
UBS Asset Management Mutual Fund 2026/Q3 +883,460 1.8%
ARK Investment Management LLC Mutual Fund 2026/Q3 +622,392 0.6%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +594,349 0.8%
JPMorgan Chase & Co. Public Company 2026/Q3 +566,624 0.4%
Global Alpha Capital Management Ltd. Mutual Fund 2026/Q3 +436,785 0.3%
Barclays Bank Plc Private Company 2026/Q3 +431,283 0.3%
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +362,114 0.3%
Royal Bank of Canada Public Company 2026/Q3 +2,567,204 1.7%
Capital Research Mutual Fund 2026/Q3 +1,315,542 13.7%
Barclays PLC Public Company 2026/Q3 +1,294,472 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Michael Hayden Independent Director Open Market Acquisition +5,000 $29.64 81,298
15 Oct 2026 Shannon L. Devers Executive VP & Chief Human Resource Officer Intent to Sell (Form 144) -1,357 $44.00 –
15 Oct 2026 Eric Swayze Executive Vice President & Head of Research Derivative Exercise and Sale -53 $43.54 22,149
15 Oct 2026 Shannon L. Devers Executive VP & Chief Human Resource Officer Derivative Exercise and Sale -1,357 $43.54 17,811
14 Oct 2026 Eric Swayze Executive Vice President & Head of Research Derivative Exercise and Retained +72 – 22,149
14 Oct 2026 Shannon L. Devers Executive VP & Chief Human Resource Officer Derivative Exercise and Retained +1,463 – 17,811
30 Aug 2026 C. Bennett Chief Scientific Officer Other Acquisition +110 $51.31 75,128
30 Aug 2026 Brett Monia Chief Executive Officer Other Acquisition +98 $51.31 242,760
30 Aug 2026 Patrick O'Neil Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary Other Acquisition +63 $51.31 59,205
30 Aug 2026 Brian Birchler Executive Vice President of Corporate & Development Operations Other Acquisition +58 $51.31 102,883
30 Jul 2026 Michael Hayden Independent Director Open Market Acquisition +20,000 $53.38 78,298
14 Jul 2026 Joan Herman Independent Director Derivative Exercise and Retained +5,220 – 51,306
14 Jul 2026 Spencer Berthelsen Independent Director Derivative Exercise and Retained +5,220 – 161,303
14 Jul 2026 Ludwig Hantson Director Other Derivative Acquisition +3,399 – 3,399
14 Jul 2026 Peter Reikes Director Other Derivative Acquisition +3,399 – 3,399
6 Jul 2026 C. Bennett Chief Scientific Officer Other Acquisition +15,000 – 75,018
6 Jul 2026 C. Bennett Chief Scientific Officer Automatic Disposition -20,536 $85.46 75,018
6 Jul 2026 C. Bennett Chief Scientific Officer Other Derivative Disposition -15,000 – 12,109
6 Jul 2026 Allene Diaz Independent Director Derivative Exercise and Sale -10,111 $85.42 3,811
6 Jul 2026 Holly Kordasiewicz Chief Development Officer Automatic Disposition -362 $84.30 22,096

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 21,165,846 12.7% 8.4
15 Oct 2026 20,653,026 12.4% 7.7
30 Sep 2026 22,508,744 13.5% 4.6
15 Sep 2026 20,890,252 12.6% 5.2
31 Aug 2026 20,924,638 12.6% 9.2
14 Aug 2026 20,909,181 12.6% 9.6

Discussion

No comments yet — be the first to weigh in on IONS.

Sign in to join the discussion.

Scroll to Top